Combination of Metformin With Gefitinib to Treat NSCLC

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to determine whether metformin in combination with gefitinib are effective in patients with previously untreated advanced or metastatic Non-Small-Cell Lung cancer with epidermal growth factor receptor (EGFR) mutations
Epistemonikos ID: 50c958a46634303e00943ea7fe2c791b60105030
First added on: May 11, 2024